EUDA Health Holdings Ltd. Files June 2024 6-K Report

Ticker: EUDAW · Form: 6-K · Filed: Jun 26, 2024 · CIK: 1847846

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

EUDA Health Holdings Ltd. (formerly 8i Acquisition 2 Corp.) filed its June 6-K, standard foreign issuer report.

AI Summary

EUDA Health Holdings Ltd. filed a Form 6-K on June 26, 2024, reporting for the month of June 2024. The company, formerly known as 8i Acquisition 2 Corp., is incorporated in D8 and has its principal executive offices in Singapore. This filing is a routine report for a foreign private issuer.

Why It Matters

This filing provides an update on EUDA Health Holdings Ltd.'s regulatory reporting status as a foreign private issuer, which is important for investors tracking the company's compliance and disclosures.

Risk Assessment

Risk Level: low — This filing is a routine report and does not contain new financial information or significant operational updates that would typically increase risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country, or that it has filed or will file with a stock exchange.

When was EUDA Health Holdings Ltd. formerly known as?

EUDA Health Holdings Ltd. was formerly known as 8i Acquisition 2 Corp.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is June 26, 2024.

Where are EUDA Health Holdings Ltd.'s principal executive offices located?

EUDA Health Holdings Ltd.'s principal executive offices are located at 1 Pemimpin Drive #12-07, One Pemimpin, Singapore 576151.

Does EUDA Health Holdings Ltd. file annual reports under Form 20-F or Form 40-F?

EUDA Health Holdings Ltd. files annual reports under Form 20-F, as indicated by the checkmark in the filing.

Filing Stats: 732 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2024-06-26 08:30:21

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: June 25, 2024 EUDA Health Holdings Limited By: /s/ Wei Wen Kelvin Chen Name: Wei Wen Kelvin Chen Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing